Skip to Main Content

Author Details

Brian G Pierce
University of Maryland Institute for Bioscience and Biotechnology Research
2005
91
40
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36806685Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity.J Biol Chem2023
37461571Evaluation of AlphaFold Antibody-Antigen Modeling with Implications for Improving Predictive Accuracy.bioRxiv2023
37140040TCRmodel2: high-resolution modeling of T cell receptor recognition using deep learning.Nucleic Acids Res2023
36806685Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity.J Biol Chem2023
37140040TCRmodel2: high-resolution modeling of T cell receptor recognition using deep learning.Nucleic Acids Res2023
37461571Evaluation of AlphaFold Antibody-Antigen Modeling with Implications for Improving Predictive Accuracy.bioRxiv2023
34655573An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development.Gastroenterology2022
36172366Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants.Front Immunol2022
35900023Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants.Protein Sci2022
35874680Structural Features of Antibody-Peptide Recognition.Front Immunol2022
35136165An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking.Commun Biol2022
34655573An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development.Gastroenterology2022
35013235Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.Nat Commun2022
35124005T cell receptors employ diverse strategies to target a p53 cancer neoantigen.J Biol Chem2022
35263223Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate.Proc Natl Acad Sci U S A2022
35874680Structural Features of Antibody-Peptide Recognition.Front Immunol2022
35900023Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants.Protein Sci2022
36172366Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants.Front Immunol2022
35013235Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.Nat Commun2022
35124005T cell receptors employ diverse strategies to target a p53 cancer neoantigen.J Biol Chem2022
35263223Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate.Proc Natl Acad Sci U S A2022
35136165An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking.Commun Biol2022
32530637<i>In Vivo</i> and <i>In Vitro</i> Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly.Mol Pharm2021
33539768An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants.Structure2021
34072451Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development.Viruses2021
34063143Structure-Based and Rational Design of a Hepatitis C Virus Vaccine.Viruses2021
33531570Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design.Sci Rep2021
34205929T Cell Receptor Genotype and <i>Ubash3a</i> Determine Susceptibility to Rat Autoimmune Diabetes.Genes (Basel)2021
32530637<i>In Vivo</i> and <i>In Vitro</i> Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly.Mol Pharm2021
33355667High-throughput modeling and scoring of TCR-pMHC complexes to predict cross-reactive peptides.Bioinformatics2021
32890396CoV3D: a database of high resolution coronavirus protein structures.Nucleic Acids Res2021
33431677Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.Proc Natl Acad Sci U S A2021
34680030Molecular Determinants of Filament Capping Proteins Required for the Formation of Functional Flagella in Gram-Negative Bacteria.Biomolecules2021
34491988Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.PLoS Comput Biol2021
33539768An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants.Structure2021
33531570Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design.Sci Rep2021
34491988Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants.PLoS Comput Biol2021
34680030Molecular Determinants of Filament Capping Proteins Required for the Formation of Functional Flagella in Gram-Negative Bacteria.Biomolecules2021
34072451Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development.Viruses2021
34063143Structure-Based and Rational Design of a Hepatitis C Virus Vaccine.Viruses2021
34205929T Cell Receptor Genotype and <i>Ubash3a</i> Determine Susceptibility to Rat Autoimmune Diabetes.Genes (Basel)2021
33431677Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.Proc Natl Acad Sci U S A2021
33355667High-throughput modeling and scoring of TCR-pMHC complexes to predict cross-reactive peptides.Bioinformatics2021
32890396CoV3D: a database of high resolution coronavirus protein structures.Nucleic Acids Res2021
31589793Geometrical characterization of T cell receptor binding modes reveals class-specific binding to maximize access to antigen.Proteins2020
31589793Geometrical characterization of T cell receptor binding modes reveals class-specific binding to maximize access to antigen.Proteins2020
32124321Modeling and Viewing T Cell Receptors Using TCRmodel and TCR3d.Methods Mol Biol2020
32286303Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas.Nat Commun2020
32483333Macromolecular modeling and design in Rosetta: recent methods and frameworks.Nat Methods2020
32878891Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization.J Virol2020
  • 1 - 50 of 182

Recommended Authors

Neeladri Sen
Institute of Structural and Molecular Biology, University College London
Career Start Year 2017
Number of shared co-authors 4
Yi Shi
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 2014
Number of shared co-authors 4
Soumya G Remesh
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2014
Number of shared co-authors 1
Markus-Frederik Bohn
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 2012
Number of shared co-authors 4
Rosalba Lepore
Basel University Hospital and University of Basel
Career Start Year 2011
Number of shared co-authors 5
Goran Bajic
Icahn School of Medicine at Mount Sinai
Career Start Year 2010
Number of shared co-authors 0
Yang Zhang
University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 15
Bjoern Peters
University of Washington School of Medicine
Career Start Year 2002
Number of shared co-authors 2
William D Martin
EpiVax Inc.
Career Start Year 2001
Number of shared co-authors 1
Rommie E Amaro
University of California
Career Start Year 2001
Number of shared co-authors 4
Heather A Carlson
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 2
Udupi A Ramagopal
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year 1998
Number of shared co-authors 1
Pavel Strop
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 2
Paul A Ramsland
College of Science, RMIT University
Career Start Year 1997
Number of shared co-authors 2
Erik Verschueren
University of California San Francisco
Career Start Year 1997
Number of shared co-authors 1
Jaume Pons
Pfizer Inc.
Career Start Year 1994
Number of shared co-authors 2
Shane Atwell
Lilly Research Laboratories
Career Start Year 1994
Number of shared co-authors 2
Sachdev S Sidhu
School of Pharmacy, University of Waterloo
Career Start Year 1993
Number of shared co-authors 2
Aw Edith Chan
The Walter and Eliza Hall Institute of Medical Research
Career Start Year 1993
Number of shared co-authors 1
Leonard Moise
EpiVax Inc.
Career Start Year 1991
Number of shared co-authors 1
Ram Samudrala
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year 1990
Number of shared co-authors 2
Natarajan Kannan
University of Georgia
Career Start Year 1990
Number of shared co-authors 0
Anne S De Groot
University of Georgia
Career Start Year 1989
Number of shared co-authors 1
Herman W T van Vlijmen
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 1
Steven C Almo
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 7
Lawrence Shapiro
Zuckerman Mind Brain Behaviour Institute
Career Start Year 1982
Number of shared co-authors 2
Ruben Abagyan
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 3
David S Moss
Institute of Structural and Molecular Biology, University of London
Career Start Year 1976
Number of shared co-authors 1
Ian A Wilson
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Career Start Year 1975
Number of shared co-authors 11
Andras Fiser
Albert Einstein College of Medicine
Career Start Year 1968
Number of shared co-authors 10

Collaborators

Zhiping Weng
University of Massachusetts Medical School
Co-authored papers 45
Thom Vreven
Visterra Inc.
Co-authored papers 15
Ragul Gowthaman
Co-authored papers 15
Johnathan D Guest
Co-authored papers 15
Howook Hwang
Co-authored papers 10
Brian M Baker
Co-authored papers 9
Iain H Moal
GSK Medicines Research Centre
Co-authored papers 7
Julian Mintseris
Co-authored papers 6
Nishant K Singh
Co-authored papers 6
Paul A Bates
The Francis Crick Institute
Co-authored papers 6
Juan Fern??ndez-Recio
Instituto de Ciencias de la Vid y del Vino (ICVV-CSIC)
Co-authored papers 6
Jeffrey J Gray
Johns Hopkins University
Co-authored papers 6
Alexandre M J J Bonvin
Bijvoet Center for Biomolecular Research, Utrecht University
Co-authored papers 6
Kevin Wiehe
Co-authored papers 6
Shoshana J Wodak
VIB-VUB Center for Structural Biology
Co-authored papers 5
Yang Wang
Co-authored papers 5
Chaok Seok
Seoul National University
Co-authored papers 5
Sheng-You Huang
Huazhong University of Science and Technology
Co-authored papers 5
Xiaoqin Zou
Dalton Cardiovascular Research Center, University of Missouri
Co-authored papers 5
Brian Jim??nez-Garc??a
Utrecht University
Co-authored papers 5
Panagiotis L Kastritis
Interdisciplinary Research Center HALOmem, Martin Luther University Halle-Wittenberg
Co-authored papers 5
Tyler Borrman
University of Massachusetts Medical School
Co-authored papers 5
Weiwei Tong
Co-authored papers 4
Sanbo Qin
University of Illinois at Chicago
Co-authored papers 4
Hasup Lee
Seoul National University
Co-authored papers 4
Joël Janin
Co-authored papers 4
Huan-Xiang Zhou
University of Illinois Chicago
Co-authored papers 4
Daisuke Kihara
Purdue University
Co-authored papers 4
Hahnbeom Park
Co-authored papers 4
Eric J Sundberg
Co-authored papers 4
Release 1.2